ΜicroRNA‑421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor‑interacting serine/threonine kinase 1

Sun,Xuecheng; Wang,Tao; Huang,Bo; Ruan,Gaobo; Xu,Aie

doi:10.3892/mmr.2019.10878

ΜicroRNA‑421 participates in vitiligo development through regulating human melanocyte survival by targeting receptor‑interacting serine/threonine kinase 1

Authors:
- Xuecheng Sun
- Tao Wang
- Bo Huang
- Gaobo Ruan
- Aie Xu
View Affiliations

Affiliations: Department of Dermatology, The Third People's Hospital of Hangzhou, Hangzhou, Zhejiang 310009, P.R. China
Published online on: December 11, 2019 https://doi.org/10.3892/mmr.2019.10878
Pages: 858-866
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vitiligo is a common localized or generalized skin pigmentation disorder. Endoplasmic reticulum (ER) stress may be implicated in the development of vitiligo. microRNA‑421 (miR‑421) has been reported to be dysregulated in various human tumors. However, there is no report to date on the role of miR‑421 in vitiligo development. The present study demonstrated that 3 µM tunicamycin (TM) increased the expression of the ER stress‑related proteins protein kinase RNA‑like endoplasmic reticulum kinase (PERK), α subunit of eukaryotic translation initiation factor 2 (eIF2α) and C/EBP homologous protein (CHOP) in human primary epidermal melanocytes. Moreover, TM suppressed melanocyte viability and induced apoptosis. Reverse transcription‑quantitative PCR analysis demonstrated that TM promoted miR‑421 expression in human melanocytes. Next, TargetScan and dual luciferase reporter gene assay indicated that receptor‑interacting serine/threonine kinase 1 (RIPK1) was a direct target of miR‑421. RIPK1 expression was significantly downregulated in TM‑induced human melanocytes. Subsequently, the effect of miR‑421 downregulation on the damage of human melanocytes induced by ER stress was investigated. Human melanocytes were transfected with inhibitor control, miR‑421 inhibitor, miR‑421 inhibitor + control‑short hairpin (sh)RNA, or miR‑421 inhibitor + RIPK1‑shRNA for 24 h and then treated with TM (3 µM) for 48 h. TM was found to upregulate PERK, eIF2α and CHOP protein expression in human melanocytes, which was reduced by an miR‑421 inhibitor. In addition, the miR‑421 inhibitor increased viability and reduced apoptosis in TM‑treated melanocytes. Furthermore, all these effects of the miR‑421 inhibitor on TM‑induced human melanocytes were reversed by RIPK1‑shRNA. Further analyses revealed that the miR‑421 inhibitor activated the phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin signaling pathway in TM‑induced human melanocytes. These data collectively suggest that miR‑421 may serve as a new treatment target in vitiligo development.

View Figures

View References

1	Ezzedine K, Eleftheriadou V, Whitton M and van Geel N: Vitiligo. Lancet. 386:74–84. 2015. View Article : Google Scholar : PubMed/NCBI
2	Jain A, Mal J, Mehndiratta V, Chander R and Patra SK: Study of oxidative stress in vitiligo. Indian J Clin Biochem. 26:78–81. 2010. View Article : Google Scholar : PubMed/NCBI
3	Silverberg JI and Silverberg NB: Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 149:159–164. 2013. View Article : Google Scholar : PubMed/NCBI
4	Karelson M, Silm H and Kingo K: Quality of life and emotional state in vitiligo in an Estonian sample: Comparison with psoriasis and healthy controls. Acta Derm Venereol. 93:446–450. 2013. View Article : Google Scholar : PubMed/NCBI
5	Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJ, Hutton SM, Amadi-Myers A, et al: Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. New Engl J Med. 362:1686–1697. 2010. View Article : Google Scholar : PubMed/NCBI
6	Alghamdi KM, Khurrum H, Taieb A and Ezzedine K: Treatment of generalized vitiligo with anti-TNF-α agents. J Drugs Dermatol. 11:534–539. 2012.PubMed/NCBI
7	Manga P, Elbuluk N and Orlow SJ: Recent advances in understanding vitiligo. F1000Res. 5(pii): F1000 Faculty Rev. 22342016. View Article : Google Scholar
8	Eleftheriadou V, Whitton ME, Gawkrodger DJ, Batchelor J, Corne J, Lamb B, Ersser S, Ravenscroft J and Thomas KS: Future research into the treatment of vitiligo: Where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol. 164:530–536. 2011.PubMed/NCBI
9	Luan Q, Jin L, Jiang CC, Tay KH, Lai F, Liu XY, Liu YL, Guo ST, Li CY, Yan XG, et al: RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy. 11:975–994. 2015. View Article : Google Scholar : PubMed/NCBI
10	Šahmatova L, Tankov S, Prans E, Aab A, Hermann H, Reemann P, Pihlap M, Karelson M, Abram K, Kisand K, et al: MicroRNA-155 is dysregulated in the skin of patients with vitiligo and inhibits melanogenesis-associated genes in melanocytes and keratinocytes. Acta Derm Venereol. 96:742–747. 2016.PubMed/NCBI
11	Bijkerk R, de Bruin RG, van Solingen C, van Gils JM, Duijs JM, van der Veer EP, Rabelink TJ, Humphreys BD and van Zonneveld AJ: Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation. Kidney Int. 89:1268–1280. 2016. View Article : Google Scholar : PubMed/NCBI
12	Zu Y, Yang Y, Zhu J, Bo X, Hou S, Zhang B, Qiu J and Zheng J: MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. Am J Cancer Res. 6:2502–2513. 2016.PubMed/NCBI
13	Li Q, Zhang X, Li N, Liu Q and Chen D: miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer. Biochem Biophys Res Commun. 485:506–512. 2017. View Article : Google Scholar : PubMed/NCBI
14	Tian W, Wang G, Liu Y, Huang Z, Zhang C, Ning K, Yu C, Shen Y, Wang M, Li Y, et al: The miR-599 promotes non-small cell lung cancer cell invasion via SATB2. Biochem Biophys Res Commun. 485:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
15	Hao J, Zhang S, Zhou Y, Liu C, Hu X and Shao C: MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun. 406:552–557. 2011. View Article : Google Scholar : PubMed/NCBI
16	Wu JH, Yao YL, Gu T, Wang ZY, Pu XY, Sun WW, Zhang X, Jiang YB and Wang JJ: MiR-421 regulates apoptosis of BGC-823 gastric cancer cells by targeting caspase-3. Asian Pac J Cancer Prev. 15:5463–5468. 2014. View Article : Google Scholar : PubMed/NCBI
17	Pasparakis M and Vandenabeele P: Necroptosis and its role in inflammation. Nature. 517:311–320. 2015. View Article : Google Scholar : PubMed/NCBI
18	Schneider AT, Gautheron J, Feoktistova M, Roderburg C, Loosen SH, Roy S, Benz F, Schemmer P, Büchler MW, Nachbur U, et al: RIPK1 Suppresses a TRAF2-dependent pathway to liver cancer. Cancer Cell. 31:94–109. 2017. View Article : Google Scholar : PubMed/NCBI
19	Saeed WK and Jun DW: Necroptosis: An emerging type of cell death in liver diseases. World J Gastroenterol. 20:12526–12532. 2014. View Article : Google Scholar : PubMed/NCBI
20	Shan B, Pan H, Najafov A and Yuan J: Necroptosis in development and diseases. Genes Dev. 32:327–340. 2018. View Article : Google Scholar : PubMed/NCBI
21	Cao C and Wan Y: Parameters of protection against ultraviolet radiation-induced skin cell damage. J Cell Physiol. 220:277–284. 2009. View Article : Google Scholar : PubMed/NCBI
22	Cao C, Huang X, Han Y, Wan Y, Birnbaumer L, Feng GS, Marshall J, Jiang M and Chu WM: Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal. 2:ra172009. View Article : Google Scholar : PubMed/NCBI
23	Cao C, Lu S, Jiang Q, Wang WJ, Song X, Kivlin R, Wallin B, Bagdasarian A, Tamakloe T, Chu WM, et al: EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells. Cell Signal. 20:1830–1838. 2008. View Article : Google Scholar : PubMed/NCBI
24	Cheng LB, Cheng L, Bi HE, Zhang ZQ, Yao J, Zhou XZ and Jiang Q: Alpha-melanocyte stimulating hormone protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling. Biochem Biophys Res Commun. 443:447–452. 2014. View Article : Google Scholar : PubMed/NCBI
25	Kadekaro AL, Kavanagh R, Kanto H, Terzieva S, Hauser J, Kobayashi N, Schwemberger S, Cornelius J, Babcock G, Shertzer HG, et al: Alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65:4292–4299. 2005. View Article : Google Scholar : PubMed/NCBI
26	Wan J, Lin F, Zhang W, Xu A, DeGiorgis J, Lu H and Wan Y: Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes. Int J Biol Sci. 13:391–400. 2017. View Article : Google Scholar : PubMed/NCBI
27	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
28	Le Poole IC, Das PK, van den Wijngaard RM, Bos JD and Westerhof W: Review of the etiopathomechanism of vitiligo: A convergence theory. Exp Dermatol. 2:145–153. 1993. View Article : Google Scholar : PubMed/NCBI
29	Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J and Young K: Vitiligo: Concise evidence based guidelines on diagnosis and management. Postgrad Med J. 86:466–471. 2010. View Article : Google Scholar : PubMed/NCBI
30	Gianfaldoni S, Wollina U, Tirant M, Tchernev G, Lotti J, Satolli F, Rovesti M, França K and Lotti T: Herbal compounds for the treatment of vitiligo: A review. Open Access Maced J Med Sci. 6:203–207. 2018. View Article : Google Scholar : PubMed/NCBI
31	Lotti T, Wollina U, Tchernev G, Valle Y, Lotti J, França K, Satolli F, Rovesti M, Tirant M, Lozev I, et al: An innovative therapeutic protocol for Vitiligo: Experience with the use of fraxel herbium laser, topical latanoprost and successive irradiation with UVA-1 Laser. Open Access Maced J Med Sci. 6:49–51. 2018. View Article : Google Scholar : PubMed/NCBI
32	Mehrgou A and Akouchekian M: Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease. J Res Med Sci. 22:1302017. View Article : Google Scholar : PubMed/NCBI
33	Spiegelman VS and Elcheva IA: Metabo-miR: miR-211 regulates mitochondrial energy metabolism in vitiligo. J Invest Dermatol. 137:1828–1830, 137. View Article : Google Scholar : PubMed/NCBI
34	Shi Q, Zhang W, Guo S, Jian Z, Li S, Li K, Ge R, Dai W, Wang G, Gao T and Li C: Oxidative stress-induced overexpression of miR-25: The mechanism underlying the degeneration of melanocytes in vitiligo. Cell Death Differ. 23:496–508. 2016. View Article : Google Scholar : PubMed/NCBI
35	Li Y, Li W, Zhang JG, Li HY and Li YM: Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma. Tumour Biol. 35:10011–10017. 2014. View Article : Google Scholar : PubMed/NCBI
36	Tan H, Qi J, Fan BY, Zhang J, Su FF and Wang HT: MicroRNA-24-3p attenuates myocardial ischemia/reperfusion injury by suppressing RIPK1 expression in mice. Cell Physiol Biochem. 51:46–62. 2018. View Article : Google Scholar : PubMed/NCBI
37	Walter P and Ron D: The unfolded protein response: From stress pathway to homeostaticregulation. Science. 334:1081–1086. 2011. View Article : Google Scholar : PubMed/NCBI
38	Li Y, Zhang Y, Fu H, Huang H, Lu Q, Qin H, Wu Y, Huang H, Mao G, Wei Z and Liao P: Hes1 knockdown exacerbates ischemic stroke following tMCAO by increasing ER stress-dependent apoptosis via the PERK/eIF2α/ATF4/CHOP signaling pathway. Neurosci Bull. Jul 15–2019.(Epub ahead of print). View Article : Google Scholar
39	Umeda J, Sano S, Kogawa K, Motoyama N, Yoshikawa K, Itami S, Kondoh G, Watanabe T and Takeda J: In vivo cooperation between Bcl-xL and the phosphoinositide 3-kinase-Akt signalingpathway for the protection of epidermal keratinocytes from apoptosis. FASEB J. 17:610–620. 2003. View Article : Google Scholar : PubMed/NCBI
40	Yue L, Ailin W, Jinwei Z, Leng L, Jianan W, Li L, Haiming C, Ling H and Chuanjian L: PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Phytomedicine. 64:1530542019. View Article : Google Scholar : PubMed/NCBI
41	Arshad Z, Rezapour-Firouzi S, Mohammadian M and Ebrahimifar: The sources of essential fatty acids for allergic and cancer patients; a connection with insight into mammalian target of rapamycin: A narrative review. Asian Pac J Cancer Prev. 19:2391–2401. 2018.PubMed/NCBI
42	Shin JM, Kim MY, Sohn KC, Jung SY, Lee HE, Lim JW, Kim S, Lee YH, Im M, Seo YJ, et al: Nrf2 negatively regulates melanogenesis by modulating PI3K/Akt signaling. PLoS One. 9:e960352014. View Article : Google Scholar : PubMed/NCBI
43	Larribere L, Khaled M, Tartare-Deckert S, Busca R, Luciano F, Bille K, Valony G, Eychene A, Auberger P, Ortonne JP, et al: PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ. 11:1084–1091. 2004. View Article : Google Scholar : PubMed/NCBI